The high success rates of 80–90% observed in Phase I trials for molecules discovered by artificial intelligence represent a significant difference compared to the average 40–65% success rates for molecules discovered by scientists.

Responsible for managing medical strategy and coordinating scientific communication processes, a Medical Manager acts as a scientific bridge between clinical research, R&D, marketing, and sales teams while conveying the clinical benefits of products to stakeholders.

Local clinical research conducted in Türkiye can contribute to a better understanding of rare diseases and support the development of new treatment methods. The country’s large patient population allows for the collection of more extensive data in such studies.

The impact of artificial intelligence on the business world, through increased efficiency, the creation of new job opportunities, innovation in business models, and emerging responsibilities in ethics and governance, is profoundly reshaping the structure of societies and economies.

In the field of rare diseases, ensuring patients have sustainable access to the treatments they need, delivering existing therapies to patients as quickly as possible, and developing new treatments will only be possible through effective collaboration among all stakeholders.

In this article published in the Fikir Liderleri Magazine, Dr. Kıvanç Öztüzün shares the needs of people with rare diseases who are trying to cope with severe earthquake conditions and the measures taken.

Trispera have focused on the field of rare diseases, both to indirectly aid these patients and their families and to address the unmet needs we see in this area.

As Trispera, we provide tailored solutions to pharmaceutical companies on regulatory compliance, market access and strategy, and aim to enable them to deliver life-saving treatments to patients.

Aging is known as the common cause of increase in all chronic diseases affecting millions of people today, also creates a heavy burden on economies worldwide.

The importance of perfecting and personalizing physician communication levels in the pharmaceutical industry is growing day by day with advancing technology and increasing competition.